Ross Melvin
Papers
2
Total Citations
19
H-Index
2
About
Ross Melvin is a leading surgical researcher whose work focuses on advancing minimally invasive techniques for adrenal gland disorders, particularly pheochromocytoma—a rare, hormone-secreting tumor. His major contributions center on evaluating the safety and efficacy of robotic and laparoscopic adrenalectomy in complex patient populations. In a landmark 2024 international multicenter study, Melvin and colleagues demonstrated that robotic adrenalectomy offers comparable outcomes to laparoscopy for pheochromocytoma, with potential advantages in operative precision, accumulating 12 citations. He further expanded this work by analyzing outcomes in patients with obesity undergoing adrenalectomy for pheochromocytoma, showing that minimally invasive approaches remain safe and effective in this high-risk group, a study that has garnered 7 citations. These investigations have helped refine surgical guidelines and expand access to advanced techniques. Melvin’s research is notable for its collaborative, multi-institutional design, providing robust, generalizable evidence that directly impacts clinical decision-making. His work is essential reading for surgeons and endocrinologists seeking to optimize care for patients with adrenal tumors.
Research Focus
Key Achievements
Top Papers
- 1
- 2